Latest News
Featured News
Select the category
Scancell completes up to US$25 million in debt financing
Scancell to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
Scancell Receives FDA Fast Track Designation for iSCIB1+
Interim Results and Business Update
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.